Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy

Mary Eapen, John P. Klein, Annalisa Ruggeri, Stephen Spellman, Stephanie J. Lee, Claudio Anasetti, William Arcese, Juliet N. Barker, Ann Baxter Lowe Lee, Maria Brown, Marcelo A. Fernandez-Vina, John Freeman, Wensheng He, Anna Paola Iori, Mary M. Horowitz, Franco Locatelli, Susana Marino, Martin Maiers, Gerard Michel, Guillermo F. SanzEliane Gluckman, Vanderson Rocha

Research output: Contribution to journalArticle

Abstract

We studied the effect of allele-level matching at human leukocyte antigen (HLA)-A, -B, -C, and -DRB1 in 1568 single umbilical cord blood (UCB) transplantations for hematologic malignancy. The primary end point was nonrelapse mortality (NRM). Only 7% of units were allele matched at HLA-A, -B, -C, and -DRB1; 15% were mismatched at 1, 26% at 2, 30% at 3, 16% at 4, and 5% at 5 alleles. In a subset, allele-level HLA match was assigned using imputation; concordance between HLA-match assignment and outcome correlation was confirmed between the actual and imputed HLA-match groups. Compared with HLA-matched units, neutrophil recovery was lower with mismatches at 3, 4, or 5, but not 1 or 2 alleles.NRM was higher with units mismatched at 1, 2, 3, 4, or 5 alleles compared with HLAmatched units. The observed effects are independent of cell dose and patient age. These data support allele-levelHLAmatching in the selection of single UCB units. (Blood. 2014;123(1):133-140).

Original languageEnglish
Pages (from-to)133-140
Number of pages8
JournalBlood
Volume123
Issue number1
DOIs
Publication statusPublished - Jan 2 2014

Fingerprint

Hematologic Neoplasms
HLA Antigens
Fetal Blood
Blood
Transplantation
Alleles
Mortality
Neutrophils
Recovery

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. / Eapen, Mary; Klein, John P.; Ruggeri, Annalisa; Spellman, Stephen; Lee, Stephanie J.; Anasetti, Claudio; Arcese, William; Barker, Juliet N.; Lee, Ann Baxter Lowe; Brown, Maria; Fernandez-Vina, Marcelo A.; Freeman, John; He, Wensheng; Iori, Anna Paola; Horowitz, Mary M.; Locatelli, Franco; Marino, Susana; Maiers, Martin; Michel, Gerard; Sanz, Guillermo F.; Gluckman, Eliane; Rocha, Vanderson.

In: Blood, Vol. 123, No. 1, 02.01.2014, p. 133-140.

Research output: Contribution to journalArticle

Eapen, M, Klein, JP, Ruggeri, A, Spellman, S, Lee, SJ, Anasetti, C, Arcese, W, Barker, JN, Lee, ABL, Brown, M, Fernandez-Vina, MA, Freeman, J, He, W, Iori, AP, Horowitz, MM, Locatelli, F, Marino, S, Maiers, M, Michel, G, Sanz, GF, Gluckman, E & Rocha, V 2014, 'Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy', Blood, vol. 123, no. 1, pp. 133-140. https://doi.org/10.1182/blood-2013-05-506253
Eapen, Mary ; Klein, John P. ; Ruggeri, Annalisa ; Spellman, Stephen ; Lee, Stephanie J. ; Anasetti, Claudio ; Arcese, William ; Barker, Juliet N. ; Lee, Ann Baxter Lowe ; Brown, Maria ; Fernandez-Vina, Marcelo A. ; Freeman, John ; He, Wensheng ; Iori, Anna Paola ; Horowitz, Mary M. ; Locatelli, Franco ; Marino, Susana ; Maiers, Martin ; Michel, Gerard ; Sanz, Guillermo F. ; Gluckman, Eliane ; Rocha, Vanderson. / Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. In: Blood. 2014 ; Vol. 123, No. 1. pp. 133-140.
@article{e1a493b90c63448daa0ea3a471aaa2da,
title = "Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy",
abstract = "We studied the effect of allele-level matching at human leukocyte antigen (HLA)-A, -B, -C, and -DRB1 in 1568 single umbilical cord blood (UCB) transplantations for hematologic malignancy. The primary end point was nonrelapse mortality (NRM). Only 7{\%} of units were allele matched at HLA-A, -B, -C, and -DRB1; 15{\%} were mismatched at 1, 26{\%} at 2, 30{\%} at 3, 16{\%} at 4, and 5{\%} at 5 alleles. In a subset, allele-level HLA match was assigned using imputation; concordance between HLA-match assignment and outcome correlation was confirmed between the actual and imputed HLA-match groups. Compared with HLA-matched units, neutrophil recovery was lower with mismatches at 3, 4, or 5, but not 1 or 2 alleles.NRM was higher with units mismatched at 1, 2, 3, 4, or 5 alleles compared with HLAmatched units. The observed effects are independent of cell dose and patient age. These data support allele-levelHLAmatching in the selection of single UCB units. (Blood. 2014;123(1):133-140).",
author = "Mary Eapen and Klein, {John P.} and Annalisa Ruggeri and Stephen Spellman and Lee, {Stephanie J.} and Claudio Anasetti and William Arcese and Barker, {Juliet N.} and Lee, {Ann Baxter Lowe} and Maria Brown and Fernandez-Vina, {Marcelo A.} and John Freeman and Wensheng He and Iori, {Anna Paola} and Horowitz, {Mary M.} and Franco Locatelli and Susana Marino and Martin Maiers and Gerard Michel and Sanz, {Guillermo F.} and Eliane Gluckman and Vanderson Rocha",
year = "2014",
month = "1",
day = "2",
doi = "10.1182/blood-2013-05-506253",
language = "English",
volume = "123",
pages = "133--140",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy

AU - Eapen, Mary

AU - Klein, John P.

AU - Ruggeri, Annalisa

AU - Spellman, Stephen

AU - Lee, Stephanie J.

AU - Anasetti, Claudio

AU - Arcese, William

AU - Barker, Juliet N.

AU - Lee, Ann Baxter Lowe

AU - Brown, Maria

AU - Fernandez-Vina, Marcelo A.

AU - Freeman, John

AU - He, Wensheng

AU - Iori, Anna Paola

AU - Horowitz, Mary M.

AU - Locatelli, Franco

AU - Marino, Susana

AU - Maiers, Martin

AU - Michel, Gerard

AU - Sanz, Guillermo F.

AU - Gluckman, Eliane

AU - Rocha, Vanderson

PY - 2014/1/2

Y1 - 2014/1/2

N2 - We studied the effect of allele-level matching at human leukocyte antigen (HLA)-A, -B, -C, and -DRB1 in 1568 single umbilical cord blood (UCB) transplantations for hematologic malignancy. The primary end point was nonrelapse mortality (NRM). Only 7% of units were allele matched at HLA-A, -B, -C, and -DRB1; 15% were mismatched at 1, 26% at 2, 30% at 3, 16% at 4, and 5% at 5 alleles. In a subset, allele-level HLA match was assigned using imputation; concordance between HLA-match assignment and outcome correlation was confirmed between the actual and imputed HLA-match groups. Compared with HLA-matched units, neutrophil recovery was lower with mismatches at 3, 4, or 5, but not 1 or 2 alleles.NRM was higher with units mismatched at 1, 2, 3, 4, or 5 alleles compared with HLAmatched units. The observed effects are independent of cell dose and patient age. These data support allele-levelHLAmatching in the selection of single UCB units. (Blood. 2014;123(1):133-140).

AB - We studied the effect of allele-level matching at human leukocyte antigen (HLA)-A, -B, -C, and -DRB1 in 1568 single umbilical cord blood (UCB) transplantations for hematologic malignancy. The primary end point was nonrelapse mortality (NRM). Only 7% of units were allele matched at HLA-A, -B, -C, and -DRB1; 15% were mismatched at 1, 26% at 2, 30% at 3, 16% at 4, and 5% at 5 alleles. In a subset, allele-level HLA match was assigned using imputation; concordance between HLA-match assignment and outcome correlation was confirmed between the actual and imputed HLA-match groups. Compared with HLA-matched units, neutrophil recovery was lower with mismatches at 3, 4, or 5, but not 1 or 2 alleles.NRM was higher with units mismatched at 1, 2, 3, 4, or 5 alleles compared with HLAmatched units. The observed effects are independent of cell dose and patient age. These data support allele-levelHLAmatching in the selection of single UCB units. (Blood. 2014;123(1):133-140).

UR - http://www.scopus.com/inward/record.url?scp=84891778061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891778061&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-05-506253

DO - 10.1182/blood-2013-05-506253

M3 - Article

AN - SCOPUS:84891778061

VL - 123

SP - 133

EP - 140

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -